# clm_4BA44A742FE5

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 3,661,000,000 United States dollar  
valid_from: 2022-12-31  
valid_to: 2023-03-31  
published: 2023-02-09  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_DD0F42269A48  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 3,661,000,000 United States dollar", as of 2022-12-31 (until 2023-03-31). Claim clm_4BA44A742FE5, https://asof.is/claim/clm_4BA44A742FE5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815423000017/0000318154-23-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2022, filed 2023-02-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815423000017/0000318154-23-000017-index.htm (primary, SEC EDGAR 10-K FY2022, published 2023-02-09)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 3,653,000,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_4BA44A742FE5](/claim/clm_4BA44A742FE5.md) | [clm_2983532AC508](/claim/clm_2983532AC508.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.